These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 17880600

  • 1. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
    Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP, National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II).
    Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
    [Abstract] [Full Text] [Related]

  • 2. Blood donor screening for parvovirus B19 in Germany and Austria.
    Schmidt M, Themann A, Drexler C, Bayer M, Lanzer G, Menichetti E, Lechner S, Wessin D, Prokoph B, Allain JP, Seifried E, Hourfar MK.
    Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
    Thomas I, Di Giambattista M, Gérard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R.
    Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP.
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [Abstract] [Full Text] [Related]

  • 7. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
    Grabarczyk P, Korzeniowska J, Liszewski G, Kalińska A, Sulkowska E, Krug-Janiak M, Kopacz A, Łetowska M, Brojer E.
    Przegl Epidemiol; 2012 Sep; 66(1):7-12. PubMed ID: 22708291
    [Abstract] [Full Text] [Related]

  • 8. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE.
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S.
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS.
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors.
    Henriques I, Monteiro F, Meireles E, Cruz A, Tavares G, Ferreira M, Araújo F.
    Transfus Apher Sci; 2005 Nov; 33(3):305-9. PubMed ID: 16203176
    [Abstract] [Full Text] [Related]

  • 13. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
    Bonvicini F, Gallinella G, Cricca M, Ambretti S, Delbarba S, Musiani M, Zerbini M.
    J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
    Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W.
    Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
    [Abstract] [Full Text] [Related]

  • 16. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
    Pichl L, Heitmann A, Herzog P, Oster J, Smets H, Schottstedt V.
    Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
    [Abstract] [Full Text] [Related]

  • 17. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N, Ağaçfidan A, Ağirbaşli H, Işik DM, Bozkaya E, Gedikoğlu G, Badur S.
    Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
    [Abstract] [Full Text] [Related]

  • 18. Improved detection of acute parvovirus B19 infection by immunoglobulin M EIA in combination with a novel antigen EIA.
    Corcoran A, Kerr S, Elliott G, Koppelman M, Doyle S.
    Vox Sang; 2007 Oct; 93(3):216-22. PubMed ID: 17845258
    [Abstract] [Full Text] [Related]

  • 19. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT.
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
    Baylis SA, Shah N, Minor PD.
    J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.